APA (7th ed.) Citation

Charpentier, J., Waget, A., Klopp, P., Magnan, C., Cruciani-Guglielmacci, C., Lee, S. J., . . . Grasset, E. (2018). Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice. American journal of physiology: Gastrointestinal and liver physiology, 315(5), G671-G684. https://doi.org/10.1152/ajpgi.00348.2017

Chicago Style (17th ed.) Citation

Charpentier, Julie, Aurélie Waget, Pascale Klopp, Christophe Magnan, Céline Cruciani-Guglielmacci, Shin Jae Lee, Rémy Burcelin, and Estelle Grasset. "Lixisenatide Requires a Functional Gut-vagus Nerve-brain Axis to Trigger Insulin Secretion in Controls and Type 2 Diabetic Mice." American Journal of Physiology: Gastrointestinal and Liver Physiology 315, no. 5 (2018): G671-G684. https://doi.org/10.1152/ajpgi.00348.2017.

MLA (9th ed.) Citation

Charpentier, Julie, et al. "Lixisenatide Requires a Functional Gut-vagus Nerve-brain Axis to Trigger Insulin Secretion in Controls and Type 2 Diabetic Mice." American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 315, no. 5, 2018, pp. G671-G684, https://doi.org/10.1152/ajpgi.00348.2017.